"Tension, in the long run, is a more dangerous force than any feud known to man.” ? Criss Jami, Killosophy
Today we revisit a small cap developmental concern we have not taken an in-depth look at in just under two years, and then when it was known by a different name. Our updated investment analysis is presented in the paragraphs below.
Company Overview:
Immunic (IMUX) is a San Diego, California-based clinical stage biopharmaceutical company. The company is focused on developing selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases.